What is the bioavailability of this medication after subcutaneous administration?
Amjevita (Adalimumab)
Status:
Open Feb 05, 2026 - 12:03 PM
1answer
Answer
Feb 05, 2026 - 12:03 PM
The bioavailability is 64% after subcutaneous injection, which refers to the proportion of the drug that enters circulation and can have an active effect. Knowing the bioavailability helps patients and providers understand how efficiently the drug works.
View More Product Details
Amjevita (Adalimumab)
Amjevita is a solution for arthritis and psoriasis. Buy Amjevita online from Canada Pharmacy at a low price. Save on each purchase!
View Details
View all Amjevita (Adalimumab) Questions & Answers
